Rehabilitation of the patient with brain tumor

Archives of Physical Medicine and Rehabilitation

Volumn 79, Issue 3 SUPPL. 1, 1998, Pages

  Bell, Kathleen R ^a   O'Dell, Michael W ^b,c   Barr, Karen ^d   Yablon, Stuart A ^e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c South Shore University Hospital Zucker School of Medicine at Hofstra Northwell   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e METHODIST REHABILITATION CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; ETOPOSIDE; HEPARIN; LOMUSTINE; LOW MOLECULAR WEIGHT HEPARIN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROCARBAZINE; PSYCHOSTIMULANT AGENT; VINCRISTINE; WARFARIN;

ALOPECIA; BLOOD TOXICITY; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER RADIOTHERAPY; COGNITIVE DEFECT; DIET SUPPLEMENTATION; FAMILY; FUNCTIONAL DISEASE; GENE THERAPY; HUMAN; LUNG FIBROSIS; MOTOR DYSFUNCTION; NAUSEA; NEPHROTOXICITY; OTOTOXICITY; PROGNOSIS; PSYCHOTHERAPY; QUALITY OF LIFE; RADIATION NECROSIS; RADIOSURGERY; REVIEW; SEIZURE; STOMATITIS; VEIN THROMBOSIS; VOMITING; WORK RESUMPTION;

EID: 0031941442     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(98)90120-4     Document Type: Review

References (127)

1. Radhakrishnan K, Bohnen NI, Kurland L. Epidemiology of brain tumors. In: Morantz RA, Walsh JW, editors. Brain tumors: a comprehensive text. New York: Marcel Dekker, 1994:1-18.
2. Prados MD, Wilson CB. Neoplasms of the central nervous system. In: Holland JF, Bast RC Ir, Morton DL, Frei E III, Kufe DW, Seichselbaum RR, editors. Cancer medicine. Vol 1. 4th ed. Baltimore: Williams & Wilkins, 1997:1471.
3. Osborn, A. Diagnostic neuroradiology. St. Louis: Mosby, 1994.
4. Fuller GN. Classification and biology of brain tumors. In: Youmans J, editor. Neurological surgery. Vol 4. Philadelphia:Saunders, 1996:2495-520.
5. Bradley WG. Pathology of nervous system tumors. In: Heffner RE, editor. Neurology in clinical practice. Vol 2. Boston: Butterworth-Heinemann, 1996:1091-108.
6. Thapar K. Brain edema, increased intracranial pressure, vascular effects, and other epiphenomena of human brain tumors. In: Kaye AH, editor. Brain tumors. New York: Churchill Livingstone, 1995: 163-91.
7. Greenberg MS. Handbook of neurosurgery. Vol 1. Lakeland: Greenberg Graphics, 1997: 240-322.
8. Vandenberg SR. Current concepts of the histopathological classification of tumors of the central nervous system. In: Thomas DG, editor. Malignant brain tumours. London: Springer-Verlag, 1995:29-96.
9. Division of Neuropathology, Brigham and Women's Hospital and Children's Hospital. Neuropathology of central nervous system tumors. In: Black PM, editor. Cancer of the nervous system. Cambridge: Blackwell Science, 1997:24-53.
10. Laws ER Jr, Taylor WF, Clifton MB, Okazaki H. Neurosurgical management of low-grade astrocytoma. J Neurosurg 1984;61:665-73.
11. McDermott MW. Meningiomas. In: Youmans J, editor. Neurological surgery. Philadelphia: Saunders, 1996:2782-823.
12. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel S, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer 1988;62:2461-5.
13. Harner SG. Clinical findings in patients with acoustic neurinoma. Mayo Clinic Proc 1983; 58:721-8.
14. Nuggent JL, Bunn PA Jr, Matthews MJ, Ihde DC, Cohen MH, Gazdar A, et al. CNS metastases in small cell lung bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 1979;44:1885-93.
15. Kindt GW. The pattern of location of cerebral metastatic tumors. J Neurosurgery 1964;21: 54-7.
16. Patchell RA. Metastatic brain tumors. Neurol Clin 1995;13(4): 915-25.
17. Fine HA, Dear KBG, Loeffler JS, Black P McL, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-97.
18. Flowers A, Levin VA. Chemotherapy for brain tumors. In: Kaye AH, Laws ER Jr, editors. Brain tumors: an encyclopedic approach. New York: Churchill Livingstone, 1995:349-60.
19. Wright DC, Delaney TF, Buckner JC. Treatment of metastatic cancer to the brain. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: Lippincott, 1993:2170-86.
20. Leibel SA, Sheline GE. Radiation therapy for neoplasms of the brain. J Neurosurg 1987;66:1-22.
21. Black PMcL. Brain tumors (Parts I and II). N Engl J Med 1991;324:1471-6,1555-64.
22. Garden AS, Maor MH, Yung WKA, Bruner JM, Woo SY, Moser RP, et al. Outcome and patterns of failure following limited-volume radiation for malignant astrocytomas. Radiother Oncol 1991;20: 99-110.
23. Morantz RA. Radiation therapy in the treatment of cerebral astrocytoma. Neurosurgery 1987;20:975-82.
24. Bernstein M, Laperriere N, Glen J, Leung P, Thomason C, Landon AE. Brachytherapy for recurrent malignant astrocytoma. Int J Radiat Oncol Biol Phys 1994;30:1213-7.
25. Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 1980;6:1215-28.
26. Larson DA, Gutin PH, Leibel SA, Phillips TL, Sneed PK, Wara WM. Stereotaxic irradiation of brain tumors. Cancer 1990;65:792-9.
27. Loeffler JS, Alexander E III, Wen PY, Shea WM, Coleman CN, Kooy HM, et al. Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J Natl Cancer Inst 1990;82:1918-21.
28. Wen PY, Alexander E III, Black PM, Fine HA, Riese N, Levin JM, et al. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer 1994;73:3029-36.
29. Hall WA, Djalilian HR, Sperduto PW, Cho KH, Gerbi BJ, Gibbons JP, et al. Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 1995;13:1642-8.
30. Karim ABMF. Radiation therapy and radiosurgery for brain tumors. In: Kay AH, Laws ER Jr, editors. Brain tumors: an encyclopedic approach. New York: Churchill Livingstone, 1995:331-48.
31. Lunsford LD, Flickinger J, Coffey RJ. Stereotactic gamma knife radiosurgery: initial North Americal experience in 207 patients. Arch Neurol 1990;47:169-75.
32. Valentino V, Mirri MA, Schinaia G, Dalle Ore G. Linear accelerator and Greitz-Bergstrom's Head Fixation System in radiosurgery of single cerebral metastases. A report of 86 cases. Acta Neurochir (Wien) 1993;121:140-5.
33. Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman JL, Shaw EG, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994;28:797-802.
34. Loeffler JS, Kooy HM, Wen PY, Fine HA, Cheng C-W, Mannarino EG, et al. The treatment of recurrent brain metatases with stereotactic radiosurgery. J Clin Oncol 1990;8:576-82.
35. Weitzner MA, Meyers CA. Quality of life and neurobehavioral functioning in patients with malignant gliomas. Bailliere's Clin Neurol 1996;2:425-39.
36. Levin VA, Galin PH, Leibel S. Neoplasms of the central nervous system. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice. 4th ed. Philadelphia: Lippincott, 1993: 1679-737.
37. Maciunas RJ, Berger MS, Copeland B, Mayberg MR, Selker R, Allen GS. A technique for interactive image-guided neurosurgical intervention in primary tumors. Neurosurg Clin 1996;7(2):245-66.
38. Ojemann JG, Miller JW, Silbergeld DL. Preserved function in brain invaded by tumor. Neurosurgery 1996;39:253-9.
39. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996;39:235-52.
40. Posner JB. Management of brain metastases. Rev Neurol (Paris) 1992;148:477-87.
41. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
42. Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JHC, Hoekstra FH, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993;33:583-90.
43. Bindal RK, Sawaya R, Leavens ME, Hess KR, Taylor SH. Reoperation for recurrent metastatic brain tumors. J Neurosurg 1995;83:600-4.
44. Schackert G, Frank S, A Schackert HK. Gene therapy: approaches for the treatment of malignant gliomas. Onkologie 1996;19:16-22.
45. Culver KW. Gene therapy for malignant neoplasms of the CNS. Bone Marrow Transplant 1996;18:S6-9.
46. Jinnah HA, Friedmann T. Gene therapy and the brain. Br Med Bull 1995;51:138-48.
47. Sipos EP, Brem H. New delivery systems for brain tumor therapy. Neurol Clin 1995;13(4):813-25.
48. Seegenschmiedt MH, Feldmann HJ, Wust P, Molls M. Hyperthermia - its actual role in raditation oncology. Part IV: Thermo-radiotherapy for malignant brain tumors. Strahlenther Onkol 1995; 171:560-72.
49. Cassileth BR, Chapman CC. Alternative and complementary cancer therapies. Cancer 1996;77:1026-34.
50. Wessel CG. Alternative Medicine Homepage. University of Pittsburgh, 1997. http://www.pitt.edu/~cbw/altm.html.
51. Al-Mefty O, Kersh JE, Routh A, Smith RR. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 1990;73:502-12.
52. Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin 1991;9(4):889-99.
53. Recht LD, Lew R, Smith TW. Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 1992;31:431-6.
54. Dropcho EJ. Central nervous system injury by therapeutic irradiation. Neurol Clin 1991;9(4):969-88.
55. Schultheiss TE, Kun LE, Ang KK, Stephens LC. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 1995;31:1093-112.
56. Forsyth PA, Kelly PJ, Cascino TL, Scheithauer BW, Shaw EG, Dinapoli RP, et al. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? J Neurosurg 1995;82: 436-44.
57. Kaufman M, Swartz BE, Mandelkern M, Ropchan J, Gee M, Blahd WH. Diagnosis of delayed cerebral radiation necrosis following proton beam therapy. Arch Neurol 1990;47:474-6.
58. Kim EE, Chung S-K, Haynie TP, Kim C-G, Cho B-J, Podoloff DA, et al. Differentiation of residual or recurrent tumors from posttreatment changes with F-18-FDG PET. RadioGraphics 1992;12: 269-79.
59. 18F] fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol 1993;33:540-8.
60. 18F-fluorodeoxyglucose PET. AJR 1994;163:1459-65.
61. 99mTc-HMPAO. AJNR 1991;12:1187-92.
62. DeAngelis LM, Delattre J-Y, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39:789-96.
63. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 1994;12:627-42.
64. Curnes JT, Laster DW, Ball MR, Moody DM, Witcofski RL. MRI of radiation injury to the brain. AJR 1986;147:119-24.
65. Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC Jr. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 1994;44:2020-7.
66. Mahaley MS Jr, Mettlin C, Natarajan N, Laws ER Jr, Peace BB. National survey of patterns of care for brain tumor patients. J Neurosurg 1989;71:826-36.
67. Rasmussen T. Surgery of epilepsy associated with brain tumors. Adv Neurol 1975;8:227-39.
68. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991;32:429-45.
69. Sander JWAS, Hart YM, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990;336:1267-71.
70. Manford M, Hart YM, Sander JWAS, Shorvon SD. The National General Practice Study of Epilepsy. The syndromic classification of the International League Against Epilepsy applied to epilepsy in a general population. Arch Neurol 1992;49:801-8.
71. Cascino GD. Epilepsy and brain tumors: implications for treatment. Epilepsia 1990; 31 (Suppl 3):S37-44.
72. Boon PA, Williamson PD, Fried I, Spencer DD, Novelly RA, Spencer SS, et al. Intracranial, intraaxial, space-occupying lesions in patients with intractable partial seizures: an anatomoclinical, neuropsychological, and surgical correlation. Epilepsia 1991;32:467-76.
73. Franceschetti S, Binelli S, Casazza M, Lodrini S, Panzica F, Pluchino F, et al. Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumors. Acta Neurochir (Wien) 1990;103: 47-51.
74. Hart YM, Sander JWAS, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy. Recurrence after a first seizure. Lancet 1990;336:1271-4.
75. Kirkpatrick PJ, Honavar M, Janota I, Polkey CE. Control of temporal lobe epilepsy following en bloc resection of low-grade tumors. J Neurosurg 1993;78:19-25.
76. Kvam DA, Loftus CM, Copeland B, Quest DO. Seizures during the immediate postoperative period. Neurosurgery 1983;12:14-7.
77. Matthew E, Sherwin AL, Welner SA, Odusote K, Stratford JG. Seizures following intracranial surgery: incidence in the first postoperative week. Can J Neurol Sci 1980;7:285-90.
78. Cohen N, Strauss G, Lew R, Silver D, Recht L. Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis. J Clin Oncol 1988;6: 1621-4.
79. Shaw MDM. Post-operative epilepsy and the efficacy of anticonvulsant therapy. Acta Neurochir 1990;Suppl 50:55-7.
80. North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB. Phenytoin and postoperative epilepsy. J Neurosurg 1983:58:672-7.
81. Glantz MJ, Cole BF, Friedberg MH, Lathi E, Choy H, Furie K, et al. A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996;46:985-91.
82. Hamilton MG, Hull RD, Pineo GF. Prophylaxis of venous thromboembolism in brain tumor patients. J Neurooncol 1994;22:111-26.
83. Sawaya R, Zuccarello M, Elkalliny M, Nishiyama H. Postoperative venous thromboembolism and brain tumors. Part I: Clinical profile. J Neurooncol 1992;14:119-25.
84. Sawaya R, Glas-Greenwalt P. Postoperative venous thromboembolism and brain tumors. Part II: Hemostatic profile. J Neurooncol 1992;14:127-34.
85. Sawaya R, Highsmith RF. Postoperative venous thromboembolism and brain tumors. Part III: Biochemical profile. J Neurooncol 1992;14:113-8.
86. Bucci MN, Papadopoulos SM, Chen JC, Campbell JA, Hoff JT. Mechanical prophylaxis of venous thrombosis in patients undergoing craniotomy: a randomized trial. Surg Neurol 1989;32:285-8.
87. Norris LK, Grossman SA. Treatment of thromboembolic complications in patients with brain tumors. J Neurooncol 1994;22:127-37.
88. Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol 1996;30:61-9.
89. Archibald YM, Lunn D, Ruttan LA, MacDonald DR, del Maestro RF, Barr HWK, et al. Cognitive functioning in long-term surviviors of high-grade glioma. J Neurosurg 1994;80:247-53.
90. Taphoorn MJB, Schiphorst AK, Snoek FJ, Lindeboom J, Wolbers JG, Karim ABMF, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 1994;36:48-54.
91. Batchelor T, DeAngelis LM. Medical management of cerebral metastases. Neurosurg Clin North Am 1996;7(3):435-46.
92. Meyers CA, Scheibel RS. Early detection and diagnosis of neurobehavioral disorders associated with cancer and its treatment. Oncology (Williston Park) 1990;4:115-22.
93. Davies E, Clarke C, Hopkins A.Malignant cerebral glioma I: survival, disability, and morbidity after radiotherapy. BMJ 1996;313: 1507-12.
94. Batchelor TT, Taylor LP, Thaler HT, Posner JB, DeAngelis LM. Steroid myopathy in cancer patients. Neurology 1997;48:1234-8.
95. Karnofsky D, Burchenal JH. Clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, editor. Evaluation of chemotherapy agents. New York: Columbia Univ Press, 1949:191-205.
96. Meyers CA, Weitzner MA. Neurobehavioral functioning and quality of life in patients treated for cancer of the central nervous system. Curr Opin Oncol 1995;7:197-200.
97. Meyers CA. Neuropsychological aspects of cancer and cancer treatment. In: Garden FH, Grabois M, editors. Physical medicine and rehabilitation: State of the art reviews. Philadelphia: Hanley & Belfus, 1994:229-41.
98. Weitzner MA, Meyers CA, Byrne K. Psychosocial functioning and quality of life in patients with primary brain tumors. J Neurosurg 1996;84:29-34.
99. Giovagnoli AR, Tamburini M, Boiardi A. Quality of life in brain tumor patients. J Neurooncol 1996;30:71-80.
100. Mackworth N, Fobair P, Prados MD. Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neurooncol 1992;14:243-53.
101. Meyers CA, Boake C. Neurobehavioral disorders in brain tumor patients: rehabilitation strategies. Can Bull 1993;4:362-4.
102. Ragnarsson KT. Principles of cancer rehabilitation medicine. In: Holland JF, Bast RC Jr, Morton DL, Frei E III, Kufe DW, Seichselbaum RR, editors. Cancer medicine. Vol I. Baltimore: Williams & Wilkins, 1997:1371-2.
103. Newton HB, Newton C, Pearl D, Davidson T. Swallowing assessment in primary brain tumor patients with dysphagia.Neurology 1994;44:1927-32.
104. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology 1993;43:1678-83.
105. Suwanwela N, Phanthumchinda K, Kaoropthum S. Headache in brain tumor: a cross-sectional study. Headache 1994;34:435-8.
106. Salander P, Karlsson T, Bergenheim T, Henriksson R. Long-term memory deficits in patients with malignant gliomas. J Neurooncol 1995;25:227-38.
107. Weitzner MA, Meyers CA, Valentine AD. Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatr Clin Neurosci 1995;7:347-50.
108. Kreeger L, Duncan A, Cowap J. Psychostimulants used for opioidinduced drowsiness. J Pain Symptom Manage 1996;11(10):1-2.
109. Olin J, Masand P. Psychostimulants for depression in hospitalized cancer patients. Psychosomatics 1996;37:57-62.
110. Martens N, Davies B. The work of patients and spouses in managing advanced cancer at home. Hospice J 1990;6(2):55-73.
111. Salander P. Brain tumor as a threat to life and personality: the spouse's perspective. J Psychosoc Oncol 1996;14(3):1-18.
112. Newton C, Mateo MA. Uncertainty: strategies for patients with brain tumor and their family. Cancer Nurs 1994;17(2):137-40.
113. Rothstein MA, Kennedy K, Ritchie KJ, Pyle K. Are cancer patients subject to employment discrimination? Oncology (Williston Park) 1995;9(12):1303-6.
114. Razavi D, Delvaux N, Br'edart A, Autier P, Bron D, Debusscher L, et al. Professional rehabilitation of lymphoma patients: a study of psychosocial factors associated with return to work. Support Care Cancer 1993;1(5):276-8.
115. Satariano WA, DeLorenze GN. The likelihood of returning to work after breast cancer. Public Health Rep 1996;111:236-41.
116. Kleinberg L, Wallner K, Malkin MG. Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys 1993;26:129-33.
117. Brennan MJ, DePompolo RW, Garden FH. Cardiovascular, pulmonary, and cancer rehabilitation. 3. Cancer rehabilitation. Arch Phys Med Rehabil 1996;77:S52-8.
118. Galinsky MJ, Schopler JH. Negative experiences in support groups. Social Work Health Care 1994;20(1):77-95.
119. Hitch PJ, Fielding RG, Llewelyn SP. Effectiveness of self-help and support groups for cancer patients: a review. Psychol Health 1994;9: 437-48.
120. Glajchen M, Magen R. Evaluating process, outcome, and satisfaction in community-based cancer support groups. Social Work Groups 1995;18(1):27-40.
121. Alter CL, Fleishman SB, Kornblish AB, Hollan JC. Supportive telephone intervention for patients receiving chemotherapy. Psychosomatics 1996;37:425-31.
122. Glimelius B, Birgegard G, Hoffman K, Hagnego C. A comprehensive cancer care project to improve the overall situation of patients receiving intensive chemotherapy. J Psychosocial One 1993;11(1): 17-40.
123. Weinberg N, Schmale JD, Uken J, Wessel K. Computer-mediated support groups. Social Work Groups 1995;17(4):43-54.
124. Balfour HM. When does palliative care begin? A needs assessment of cancer patients with recurrent diseases. J Palliative Care 1995; 11(3):53.
125. Meyers CA, Boake C, Levin VA, Ratliff DD. Symptom management, rehabilitation strategies, and improved quality of life for patients with brain tumors. In: Levin VA, editor. Cancer in the nervous system. New York: Churchill Livingstone, 1996:449-59.
126. Marciniak CM, Sliwa JA, Spill G, Heinemann AW, Semik PE. Functional outcome following rehabilitation of the cancer patient. Arch Phys Med Rehabil 1996;77:54-7.
127. Sherer M, Meyers C, Bergloff P. Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumors. Cancer 1997;80:250-7.